| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Ginsberg HN | |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| lipoprotein | Q28350 | ||
| P304 | page(s) | 839-855 | |
| P577 | publication date | 1991-09-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis | |
| P478 | volume | 14 |
| Q43828351 | Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes |
| Q44053882 | Age-related changes in fatty acids in obese offspring of streptozotocin-induced diabetic rats |
| Q35088381 | Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien |
| Q37317898 | Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography |
| Q37681939 | Antidiabetic Effect of Fresh Nopal (Opuntia ficus-indica) in Low-Dose Streptozotocin-Induced Diabetic Rats Fed a High-Fat Diet. |
| Q35179999 | Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. |
| Q74062981 | Association between dietary adherence measures and glycemic control in outpatients with type 1 diabetes mellitus and normal serum lipid levels |
| Q43990197 | Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics |
| Q29622869 | CCR2 modulates inflammatory and metabolic effects of high-fat feeding |
| Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
| Q51561727 | Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association. |
| Q51554079 | Comparison of WHO and ADA criteria for diagnosis of glucose status in adults. |
| Q37202057 | Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q37431527 | Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. |
| Q73069691 | Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators |
| Q36437781 | Effect of Korean Red Ginseng treatment on the gene expression profile of diabetic rat retina |
| Q73515095 | Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients |
| Q36323752 | Effect of functional sympathetic nervous system impairment of the liver and abdominal visceral adipose tissue on circulating triglyceride-rich lipoproteins. |
| Q51560927 | Effect of glycemic control on plasma plant sterol levels and post-heparin diamine oxidase activity in type 1 diabetic patients. |
| Q44317936 | Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes |
| Q51589992 | Effects of insulin therapy upon plasma lipid fatty acids and platelet aggregation in NIDDM with secondary failure to oral antidiabetic agents |
| Q33727061 | Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus |
| Q51585470 | Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia. |
| Q51476370 | Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. |
| Q49703070 | Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes |
| Q35395461 | Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition |
| Q77591544 | Glycated serum stimulation of macrophages in GK- and streptozotocin-rats for the proliferation of primary cultured smooth muscle cells of the aorta |
| Q28213716 | Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications |
| Q90615969 | High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes |
| Q34545440 | Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis |
| Q74069395 | Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients |
| Q51594141 | Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. |
| Q55176268 | Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care. |
| Q91795685 | Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes |
| Q51563252 | Influence of 4 weeks' intervention by exercise and diet on low-density lipoprotein subfractions in obese men with type 2 diabetes. |
| Q51542445 | Insulin improves fasting and postprandial lipemia in type 2 diabetes. |
| Q51559072 | Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). |
| Q28245597 | LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1 |
| Q43984272 | Lipaemic plasma induces haemolysis in resuspended red cell concentrate |
| Q26860086 | Lipids and the endothelium: bidirectional interactions |
| Q60730015 | Lipoprotein compositional abnormalities in type I diabetes: Effect of improved glycaemic control |
| Q44668303 | Low-density lipoprotein subclass and its correlating factors in diabetics |
| Q73437846 | Low-protein diet prevents tissue lipoprotein lipase activity increase in growing rats |
| Q54248117 | Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients. |
| Q36240026 | Management of Hyperlipidemia in Diabetes Mellitus |
| Q35209850 | Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity |
| Q71858705 | Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects |
| Q34989681 | Molecular mechanisms of diabetic cardiovascular disease |
| Q36766171 | Mouse models for studies of cardiovascular complications of type 1 diabetes |
| Q40931680 | Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group |
| Q21245718 | Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells |
| Q37996437 | PPAR agonists for the treatment of cardiovascular disease in patients with diabetes |
| Q57605929 | Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans |
| Q42821733 | Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts |
| Q34384114 | Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus |
| Q37239814 | Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial |
| Q90024212 | Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity |
| Q90304215 | Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases |
| Q47897466 | Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus |
| Q43114689 | Reduced Antioxidant Potential of LDL Is Associated With Increased Susceptibility to LDL Peroxidation in Type II Diabetic Patients |
| Q37661249 | Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. |
| Q40812889 | Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal |
| Q90539112 | Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease |
| Q41612001 | Risk factors for cardiovascular disease in children with type I diabetes: Part 1. |
| Q98725952 | Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus |
| Q35229363 | The Good, The Bad, and The Ugly in Diabetic Diets |
| Q47235233 | The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins |
| Q46781809 | The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus |
| Q89430484 | The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study |
| Q35654368 | The process of atherogenesis--cellular and molecular interaction: from experimental animal models to humans |
| Q33752800 | The treatment of hypertension and dyslipidemia in diabetes mellitus |
| Q77696859 | Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains |
| Q46703453 | Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia |
| Q36683565 | Triglycerides and disease. |
| Q47742710 | Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q40476568 | Update on the treatment of hypercholesterolemia, with a focus on hmg‐coa reductase inhibitors and combination regimens |
| Q77098045 | Vascular disease and lipids in diabetes |
Search more.